Enlivex Therapeutics
Macrophage Reprogramming Cell Therapies for Life-threatening Diseases
Active
Public
Startup
Ness Ziona
Founded 2005-09
Enlivex Therapeutics is a clinical-stage company focused on macrophage reprogramming. The company intends to develop and commercialize a drug pipeline for macrophage reprogramming in solid cancers, sepsis, COVID-19, and other indications. The company's most advanced product candidate, Allocetra, was developed for the reprogramming of diseased macrophages in…
SectorHealth Tech & Life Sciences
StagePublic
Total raised$74.9M
Employees35
Founded2005-09
HQNess Ziona
Crunchbaseenlivex-therapeutics
Patents1
Confidence91
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnologyHealthcareProviders